AGENDA:

Welcome and Introduction
Program Director- Brian G.M. Durie, MD

Presentation 1: Overview of the Treatment Landscape in Myeloma
Robert Z. Orlowski, MD, PhD
Faculty Panel Commentary, Recommendations, Audience Questions

Presentation 2: Defining High-Risk Myeloma
Ola Landgren, MD
Faculty Panel Commentary, Recommendations, Audience Questions

Presentation 3: Smoldering Myeloma: To Treat or Not to Treat?
Jesús F. San-Miguel, MD, PhD
Faculty Panel Commentary, Recommendations, Audience Question

Presentation 4: Optimal Therapies for Transplantation-Ineligible Patients
Brian G.M. Durie, MD
Faculty Panel Commentary, Recommendations, Audience Questions

Debate: Minimal Residual Disease: A Treatment Goal or a Prognostic Marker?
Philippe Moreau, MD and Jesús F. San-Miguel, MD, PhD
Conclusion: Faculty Panel Commentary, Recommendations, Audience Questions